Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis
Niyonzima, Nathalie, Bakke, Siril S., Gregersen, Ida, Holm, Sverre, Sandanger, Øystein, Orrem, Hilde L., Sporsheim, Bjørnar, Ryan, Liv, Kong, Xiang Yi, Dahl, Tuva Børresdatter, Skjelland, Mona, Sørensen, Kirsten Krohg, Rokstad, Anne Mari, Yndestad, Arne, Latz, Eicke, Gullestad, Lars, Andersen, Geir Ø., Damås, Jan Kristian, Aukrust, Pål, Mollnes, Tom E., Halvorsen, Bente, Espevik, Terje
Published in EBioMedicine (01.10.2020)
Published in EBioMedicine (01.10.2020)
Get full text
Journal Article
IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction
Orrem, Hilde L, Nilsson, Per H, Pischke, Søren E, Kleveland, Ola, Yndestad, Arne, Ekholt, Karin, Damås, Jan K, Espevik, Terje, Bendz, Bjørn, Halvorsen, Bente, Gregersen, Ida, Wiseth, Rune, Andersen, Geir Ø, Ueland, Thor, Gullestad, Lars, Aukrust, Pål, Barratt-Due, Andreas, Mollnes, Tom E
Published in Frontiers in immunology (12.09.2018)
Published in Frontiers in immunology (12.09.2018)
Get full text
Journal Article
Complement activation is a crucial pathogenic factor in catastrophic antiphospholipid syndrome
Barratt-Due, Andreas, Fløisand, Yngvar, Orrem, Hilde L, Kvam, Ann K, Holme, Pål A, Bergseth, Grethe, Tjønnfjord, Geir E, Mollnes, Tom E
Published in Rheumatology (Oxford, England) (01.07.2016)
Published in Rheumatology (Oxford, England) (01.07.2016)
Get full text
Journal Article
Soluble IL-1 receptor 2 is associated with left ventricular remodelling in patients with ST-elevation myocardial infarction
Orrem, Hilde L., Shetelig, Christian, Ueland, Thor, Limalanathan, Shanmuganathan, Nilsson, Per H., Husebye, Trygve, Aukrust, Pål, Seljeflot, Ingebjørg, Hoffmann, Pavel, Eritsland, Jan, Mollnes, Tom E., Andersen, Geir Øystein, Yndestad, Arne
Published in International journal of cardiology (01.10.2018)
Published in International journal of cardiology (01.10.2018)
Get full text
Journal Article
The IL-6 receptor inhibitor tocilizumab attenuated expression of C5a receptor 1 and 2 in patients with myocardial infarction
Orrem, Hilde L., Nilsson, Per H., Pischke, Søren E., Kleveland, Ola, Ekholt, Karin, Aukrust, Pål, Halvorsen, Bente, Gullestad, Lars, Barratt-Due, Andreas, Mollnes, Tom E.
Published in Molecular immunology (01.09.2017)
Published in Molecular immunology (01.09.2017)
Get full text
Journal Article
Acute heart failure following myocardial infarction: complement activation correlates with the severity of heart failure in patients developing cardiogenic shock
Orrem, Hilde L., Nilsson, Per H., Pischke, Søren E., Grindheim, Guro, Garred, Peter, Seljeflot, Ingebjørg, Husebye, Trygve, Aukrust, Pål, Yndestad, Arne, Andersen, Geir Ø., Barratt‐Due, Andreas, Mollnes, Tom E.
Published in ESC Heart Failure (01.06.2018)
Published in ESC Heart Failure (01.06.2018)
Get full text
Journal Article
Complement activation in acute heart failure following myocardial infarction
Orrem, Hilde L, Nilsson, Per H, Barratt-Due, Andreas, Pische, Søren E, Grindheim, Guro, Garred, Peter, Husebye, Trygve, Andersen, Geir Øystein, Mollnes, Tom Eirik
Published in Immunobiology (1979) (01.10.2016)
Published in Immunobiology (1979) (01.10.2016)
Get full text
Journal Article
Combined inhibition of C5 and CD14 efficiently attenuated the inflammatory response in a porcine model of meningococcal sepsis
Hellerud, Bernt C, Orrem, Hilde L, Dybwik, Knut, Pischke, Søren E, Baratt-Due, Andreas, Castellheim, Albert, Fure, Hilde, Bergseth, Grethe, Christiansen, Dorte, Nunn, Miles A, Espevik, Terje, Lau, Corinna, Brandtzæg, Petter, Nielsen, Erik W, Mollnes, Tom E
Published in Journal of intensive care (2017)
Published in Journal of intensive care (2017)
Get full text
Journal Article
Complement activation is a crucial pathogenic factor in catastrophic antiphospholipid syndrome
Barratt-Due, Andreas, Fløisand, Yngvar, Orrem, Hilde L, Kvam, Ann K, Holme, Pål A, Bergseth, Grethe, Tjønnfjord, Geir E, Mollnes, Tom E
Published in Rheumatology (Oxford, England) (01.07.2016)
Published in Rheumatology (Oxford, England) (01.07.2016)
Get full text
Report